Plain-English translation of NCT05617456 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying advanced technologies and techniques used during ablation procedures — a minimally invasive treatment where doctors use catheters (thin tubes) to help correct irregular heart rhythms in patients with atrial fibrillation. The study aims to determine which newer tools and personalized approaches help different patients achieve the best results and prevent the arrhythmia from coming back.
Atrial fibrillation is the most common heart rhythm problem and can lead to stroke, heart failure, and other serious complications. While ablation is an established treatment, doctors currently use many different techniques and tools depending on their training and preference. This trial exists to figure out which newer technologies and personalized treatment plans work best for which patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would undergo a catheter ablation procedure using one or more advanced technologies that your doctor believes is best for your individual situation. You would attend follow-up visits at the research center to monitor how well the treatment worked and whether your heart rhythm remained normal. The study involves about 4,100 patients worldwide and will track your outcomes over time to help doctors understand which technologies and approaches work best for different patients.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Italy